Search results
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 1 day agoOn Wednesday, Citi reaffirmed its Buy rating on AstraZeneca (NASDAQ:AZN) shares with a steady price...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News via Yahoo News· 6 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 9 hours ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court adopted a magistrate judge’s recommendations ...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 2 days agoAstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical...
AstraZeneca invests in Nucleus RadioPharmaceuticals - Minneapolis / St. Paul Business Journal
The Business Journals· 6 hours agoAfter completing a $56 million Series A funding round in 2023, Nucleus RadioPharma scored an...
AstraZeneca’s Lung, Breast Cancer Drugs Markedly Slow Disease
Bloomberg· 5 days agoAstraZeneca Plc’s lung and breast cancer drugs significantly slowed the spread of disease in two...
Nucleus RadioPharma secures Series A investment from AstraZeneca
BioPharma-Reporter· 16 hours agoThe investment from AstraZeneca marks a strategic move to further expand Nucleus's capabilities in developing targeted radiotherapies and theranostics, aimed at making cancer ...
AstraZeneca completes acquisition of biopharma company Fusion Pharma
dpa international via Yahoo Finance· 2 days agoBritish pharmaceutical company AstraZeneca on Wednesday announced the completion of the acquisition...
First Trust Advisors LP Raises Stock Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 18 hours agoFirst Trust Advisors LP grew its holdings in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 7.4% in the fourth quarter, according to its most recent filing with the Securities ...
Deutsche Bank maintains 'Hold' on AstraZeneca post ASCO conference By Investing.com
Investing.com· 2 days agoOn Monday, Deutsche Bank reiterated a Hold rating and a price target of GBP110.00 on stock of ...